{"product_id":"cleveland-clinic-27th-annual-diabetes","title":"Cleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery 2023","description":"\u003cstrong\u003eCleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery 2023 \u003c\/strong\u003eis presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 16 videos + 22 pdfs, size: 1.74 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: primary care physicians, endocrinologists, diabetes educators\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003cstrong\u003eThe 27th annual Diabetes Day: Therapeutics, Technology and Surgery \u003c\/strong\u003eis presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eA review of therapeutic options to manage both Type 1 and 2 diabetes and their complications, including a pump update, new insulins, and continuous glucose monitoring updates.\u003c\/li\u003e\n\u003cli\u003eNew data regarding metformin in pregnancy will be discussed.\u003c\/li\u003e\n\u003cli\u003eImportance of maintaining muscle mass during obesity management.\u003c\/li\u003e\n\u003cli\u003eGastroparesis associated with GLP-1 therapy and its effect on pre-op management.\u003c\/li\u003e\n\u003cli\u003eNew roles for GLP1 receptor agonists SGLT-2 inhibitors and mineralocorticoid receptor antagonists in preserving cardiac function and preventing strokes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThis year’s curriculum will also feature discussions about:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eResearch from Cleveland Clinic on non-nutritive sweeteners.\u003c\/li\u003e\n\u003cli\u003eNew treatment for nephropathy.\u003c\/li\u003e\n\u003cli\u003ePre-prandial vs post prandial exercise.\u003c\/li\u003e\n\u003cli\u003eDiabetes and dementia.\u003c\/li\u003e\n\u003cli\u003eMental health and diabetes.\u003c\/li\u003e\n\u003cli\u003eEffects of high-fat and high-protein diets on glucose control.\u003c\/li\u003e\n\u003cli\u003eDermatologic considerations in diabetes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.\u003cbr\u003e\u003cbr\u003eThere will be an optional workshop on continuous glucose monitoring designed for healthcare providers to advance the care of their patients with diabetes using continuous glucose monitoring (CGM) and other diabetes technology.\u003cbr\u003e\u003ch3\u003eAttendees will be able to:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe the efficacy and side effects of therapeutic interventions for Type 1 and Type 2 diabetes, including new insulins, closed-loop insulin pumps, smart pens, and islet and pancreas transplants.\u003c\/li\u003e\n\u003cli\u003eAnalyze new therapies and critically appraise the roles of SGLT-2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists to preserve renal and cardiac function.\u003c\/li\u003e\n\u003cli\u003eAssess goals and management strategies for treating renal insufficiency in patients with diabetes.\u003c\/li\u003e\n\u003cli\u003eEvaluate the impact of weight loss treatment options, including muscle mass preservation, in patients with Type 2 diabetes.\u003c\/li\u003e\n\u003cli\u003eCritically appraise the effects of non-nutritive sweeteners.\u003c\/li\u003e\n\u003cli\u003eDiscuss the impact and define treatment strategies for dermatologic manifestations, neurological impairment such as dementia and stroke, and managing pregnancy for patients with diabetes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho should attend?\u003c\/h3\u003e\n\u003cbr\u003eThis activity is designed for primary care physicians, endocrinologists, diabetes educators, pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who care for patients with diabetes.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eRelease Date : May 18th 2023\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCarbs in Pregnancy, How Low Can You Go.mp4\u003c\/li\u003e\n\u003cli\u003eCarbs in Pregnancy, How Low Can You Go.pdf\u003c\/li\u003e\n\u003cli\u003eContinuous Glucose Monitoring Keeping Up With Technology and Your Patients.pdf\u003c\/li\u003e\n\u003cli\u003eDiabetes Management in Older Adults.mp4\u003c\/li\u003e\n\u003cli\u003eDiabetes Management in Older Adults.pdf\u003c\/li\u003e\n\u003cli\u003eDiabetes Prevention Teplizumab.mp4\u003c\/li\u003e\n\u003cli\u003eDiabetes Prevention Teplizumab.pdf\u003c\/li\u003e\n\u003cli\u003eGlucagon in Emergency Lows, Micro Dosing and Insulin Pumps.mp4\u003c\/li\u003e\n\u003cli\u003eGlucagon in Emergency Lows, Micro Dosing and Insulin Pumps.pdf\u003c\/li\u003e\n\u003cli\u003eInsulin Update – Long, Short, Inhaled.mp4\u003c\/li\u003e\n\u003cli\u003eInsulin Update – Long, Short, Inhaled.pdf\u003c\/li\u003e\n\u003cli\u003eInsulin Without Hypoglycemia.mp4\u003c\/li\u003e\n\u003cli\u003eInsulin Without Hypoglycemia.pdf\u003c\/li\u003e\n\u003cli\u003eMedical vs Surgical Treatment for Diabetes Remission Weight Loss Aminian.pdf\u003c\/li\u003e\n\u003cli\u003eMedical vs Surgical Treatment for Diabetes Remission Weight Loss Griebeler.pdf\u003c\/li\u003e\n\u003cli\u003eMedical VS Surgical Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eMedical VS Surgical Treatment.pdf\u003c\/li\u003e\n\u003cli\u003eNeuropathy Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eNeuropathy Treatment.pdf\u003c\/li\u003e\n\u003cli\u003eNew ADA Guidelines for Hypertension and Lipids.mp4\u003c\/li\u003e\n\u003cli\u003eNew ADA Guidelines for Hypertension and Lipids.pdf\u003c\/li\u003e\n\u003cli\u003eNew Therapy for Diabetic Heart Disease.mp4\u003c\/li\u003e\n\u003cli\u003eNew Therapy for Diabetic Heart Disease.pdf\u003c\/li\u003e\n\u003cli\u003eNon-insulin Treatment in the Hospital.mp4\u003c\/li\u003e\n\u003cli\u003eNon-insulin Treatment in the Hospital.pdf\u003c\/li\u003e\n\u003cli\u003ePancreas Transplant and Islet Transplant Update.mp4\u003c\/li\u003e\n\u003cli\u003ePancreas Transplant and Islet Transplant Update.pdf\u003c\/li\u003e\n\u003cli\u003ePreserving Renal Function in Diabetes.mp4\u003c\/li\u003e\n\u003cli\u003ePreserving Renal Function in Diabetes.pdf\u003c\/li\u003e\n\u003cli\u003eRetinopathy Macular Edema.mp4\u003c\/li\u003e\n\u003cli\u003eRetinopathy Macular Edema.pdf\u003c\/li\u003e\n\u003cli\u003eUse of Insulin Pumps in Type 2 Diabetes.mp4\u003c\/li\u003e\n\u003cli\u003eUse of Insulin Pumps in Type 2 Diabetes.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 1 – CGM updates.mp4\u003c\/li\u003e\n\u003cli\u003eWorkshop 1 – CGM updates.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 1 – Novel Insulin Delivery.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 2 – Diabetic Cardiomyopathy.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 2 – Non Nutritive Sweeteners.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954380050530,"sku":"MED-AMB02228","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/5940421880903221840_121.jpg?v=1779374933","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-27th-annual-diabetes","provider":"Meducourse","version":"1.0","type":"link"}